← boothcheck

Is ISRG overvalued?

boothcheck doesn't label ISRG overvalued or undervalued, and it doesn't publish a fair value. It shows what the price assumes instead. At today's price, ISRG is priced for today's economics sustained for about 13 years, and an operating margin near 26.2% versus the 29.5% it earns today. Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium). The more the price assumes beyond what Intuitive Surgical, Inc. has actually delivered, the more has to go right to justify it. Whether that bar is too high is your call, and the full bull and bear cases are in the report.

Derived from Intuitive Surgical, Inc.'s SEC EDGAR filings via a reverse-DCF inversion. Last analyzed June 27, 2026.

Implied growth
For about13 yrs
Margin needed26.2%
Margin today29.5%
Price vs asset value4.29x
Price vs earnings power4.58x
Price vs peer multiples2.37x
Price vs forward growth1.00x
Read the full ISRG report →
Get boothcheck's read on what ISRG's price is betting on, in your inbox when it moves. No hype, no spam.
Free. Informational only, not investment advice. Unsubscribe anytime.

For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.